From: Warfarin and fibrinolysis - a challenging combination: an observational cohort study
n (%, 95% CI) | |
---|---|
Age (years)* | 70 (62-78) |
Sex; men | 28 (78%, 62-89%) |
Previous medical history | |
ischaemic heart disease | 21 (58%, 42-73%) |
hypertension | 24 (67%, 50-80%) |
diabetes | 11 (31%, 18-47%) |
myocardial infarction | 17 (47%, 32-63%) |
thrombolysis | 9 (25%, 14-41%) |
PCI or CABG | 5 (14%, 6-29%) |
use of aspirin | 2 (6%, 1-19%) |
Signs before fibrinolysis | |
cardiac arrest | 10 (28%, 16-44%) |
pulmonary oedema | 1 (3%, 0-15%) |
cardiogenic shock | 5 (14%, 6-29%) |
Warfarin | |
prior use known before fibrinolysis | 34 (94%, 81-99%) |
indication | |
atrial fibrillation | 20 (55.5%, 40-70%) |
cerebrovascular disease | 6 (17%, 7-32%) |
pulmonary embolism | 1 (3%, 0-15%) |
deep vein thrombosis | 2 (5.5%, 1-19%) |
heart valve disease | 3 (8%, 2-23%) |
cardiomyopathy | 4 (11%, 4-26%) |